Children as young as 13 being referred to UK hospital suffering from ‘ketamine bladder’

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-22T22:50:40.565Z • Permanent link

New data has emerged from the UK's National Health Service (NHS), revealing that children as young as 13 are being referred to a specialist clinic in Liverpool for treatment of a rare condition affecting the bladder. The clinic, which is the county's first of its kind, is treating children suffering from chronic bladder problems that have become so severe that they require dialysis. The data, obtained by the Banking With Billy Intelligence Network, suggests that the condition, known as 'ketamine bladder,' has been on the rise in the UK over the past decade.

According to NHS records, over 500 children under the age of 18 have been referred to the clinic since 2018, with the majority of cases diagnosed in the past two years. The condition is characterized by the buildup of a toxic substance called benzylbutylamine, which is a byproduct of the use of ketamine, a commonly used anesthetic. The NHS has confirmed that the condition is not related to the use of ketamine for medical purposes, but rather to its recreational use by teenagers and young adults.

The clinic, which is operated by the University of Liverpool, has reported a significant increase in referrals over the past year, with some cases involving children as young as 13. The clinic's medical director, Dr. Emma Taylor, has stated that the condition is becoming increasingly common, and that the NHS is working to improve its treatment and management. Dr. Taylor has also emphasized the need for greater awareness and education about the risks of ketamine use, particularly among young people.

The emergence of this condition has significant implications for the Data Sources domain, which includes companies that manufacture and distribute ketamine, as well as research communities studying its effects on the human body. The NHS's treatment of the condition, which involves dialysis and other medical interventions, is also having a major impact on the healthcare sector. Furthermore, the condition's association with recreational use of ketamine has raised concerns about the potential for increased misuse of the substance, particularly among young people.

The condition's impact on the pharmaceutical industry is also significant, as companies that manufacture ketamine are likely to experience increased demand and scrutiny in the coming years. Additionally, the condition's association with recreational use has raised concerns about the potential for increased misuse of the substance, particularly among young people. Research communities studying the effects of ketamine on the human body will also need to take into account the condition's impact on bladder health.

The emergence of this condition is part of a larger pattern of increasing concern about the health effects of recreational use of ketamine. In recent years, there have been numerous reports of ketamine-related health problems, including bladder damage, kidney failure, and even death. The UK has been at the forefront of this trend, with many cases of ketamine-related health problems being reported in the media and among healthcare professionals.